Company intelligence / Profile preview

Kolmar BNH

Seoul, Seoul Special City, South Koreakolmarbnh.co.kr ↗

Ownership: Private
Development stage: Commercial

Overview

Kolmar BNH leads the Korean market in ODM/OEM manufacturing of health supplements and functional ingredients. The company has developed several individually recognized ingredients for immune function and memory improvement. It operates at full commercial scale with GMP-certified facilities supplying over two dozen countries worldwide. No clinical trial data typical of pharmaceutical development; efficacy claims are based on regulatory recognition for food/health supplement use rather than drug approval.

Therapeutic areas: OtherImmunologyNeurology
Modalities: Small moleculeProbioticsNatural product extractProtein
Industry: Food & Nutrition

Drug pipeline

1 asset

HemoHIM

Commercial

Indications: Immune function, Fatigue

Partnerships

Korea Atomic Energy Research Institute (founding partner)Atomy Co., Ltd. (“Hemohim” distribution partner)

Beyond the preview

Go deeper on Kolmar BNH.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kolmar BNH.

Explore the full profile